The global laboratory informatics market size was valued at USD 3.3 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 4.9% from 2023 to 2030. An increase in demand for laboratory automation is expected to fuel the adoption in the coming years. Data generated by laboratories has dramatically risen in the past few decades owing to the rising technological advancements in moleculargenomicsand genetic testing practices. In addition, the shift of preference towardpersonalized medicine, cancer genomics studies, and increasing patient engagement requirements is expected to upsurge the demand forlab automationsystems.
Software solutions are becoming more user-friendly, data is moving to the cloud, and the number of startups in the field of laboratory informatics is on the rise. The cloud is becoming the norm for laboratory informatics software. Informatics providers must now have a cloud and SaaS strategy. In addition, the number of research laboratories implementing cloud, mobile, and voice technologies is increasing over time, which is boosting the demand for lab automation solutions.
The outbreak of the Coronavirus has turned the spotlight on the healthcare sector. Shortages of critical medical supplies during this pandemic have severely impacted the overall market. Almost half of the laboratories around the world were shut down and an estimated 14% of the laboratories were fully functional. Subsequently, government measures like stay-at-home orders, social distancing norms, movement restrictions, and supply chain disruptions have created a logistical problem for companies, leading to the shortages of on-premise delivery of the product in the worldwide marketplace.
On the other hand, with an unprecedented demand for COVID-19 testing worldwide, clinical labs have scaled up their operations and faced new challenges comprising development, standardization, and validation of the new methods for testing and administration of large volumes of patient specimens and test data, besides rapid and reliable reporting of test outcomes. To speed up the high demand for COVID-19 tests in clinical labs, a LIMS plays an essential role, which led to the adoption of the product.
Moreover, laboratory information systems are gaining popularity in biobanks, academic research institutes, andContract Research Organizations(横)由于相关福利。的benefits of using these systems include process optimization, improved regulatory compliance, intellectual property rights protection, and reduced throughput time. Paperless information management reduces labor costs and offers improved data quality through the elimination of errors and faster and effective data analytics.
Laboratories are critical to both manufacturing and research organizations across the life sciences and medical research industries. The primary objective of a laboratory is to ensure the generation of high-quality and reliable experiment data that conforms to the regulatory guidelines of the industry. Advances in technology combined with stringent regulatory needs and increasing commercial pressures have led to the rapid generation of vast amounts of data from various aspects comprising research and development, quality assurance, and manufacturing.
Furthermore, an increasing burden from the regulatory authorities for the implementation of lab automation systems is expected to serve this market with lucrative growth opportunities. The increasing adoption of robotics and process automation in healthcare has rendered operations reproducible and repeatable. It is now possible to set up, run, and analyze the experimental results in a shorter time. Rising penetration of high throughput systems has enabled efficient evaluation of experimental results, which increases the overall efficiency of laboratory operations.
The Laboratory Information Management Systems (LIMS) segment dominated the market and held a revenue share of over 45.0% in 2022 and is expected to witness lucrative growth over the forecast period. These systems include master data management, reporting of sample lifecycle, stability study, system and security administration, schedules, inventory, instruments, storage capacity and logistics, and analytical workflow. Demand for fully integrated services in the life sciences and research industries to minimize data management errors and improve the qualitative analysis of research information is expected to fuel the segment growth in the coming years. Owing to these factors, the LIMS segment is expected to maintain its position throughout the forecast period. In addition, the superior Electronic Lab Notebooks (ELN) system segment is anticipated to witness significant growth over the forecast period due to its increased adoption by researchers in analytical chemistry labs.
TheEnterprise Content Management(ECM) segment is anticipated to register a CAGR of 3.3% during the forecast period. The adoption of ECM is increasing over time as it offers integrated and comprehensive solutions to meet the growing challenges in the healthcare industry. ECM offers a centralized approach to capture, create, organize, access, and analyze an organization’s entire ecosystem of media, knowledge assets, and electronic documents. The services offered by companies for ECM are consultation, design, implementation, and maintenance of these software solutions.
The cloud-based segment dominated the market and accounted for a revenue share of over 40.0% in 2022 and is expected to witness lucrative growth over the forecast period. Cloud-based technology helps in storing large amounts of data remotely to allow free space on devices and facilitate data retrieval according to client needs. The technology comprises three services including Platform as a Service (PaaS), Infrastructure as a Service (IaaS), and Software as a Service (SaaS). The cloud-based analytics software is available as SaaS-based services. IBM offers its Watson Analytic services on the SaaS platform.
Companies such as Core Informatics and LabVantage Solutions, Inc. are offering cloud-based services for LIMS. An increase in the adoption of cloud-based platforms by CROs due to associated benefits such as reduction in labor cost, saving time and space spent for system implementation, and secured access to clinical information. Real-time data tracking, remote access to data, and an easy ecosystem are some other benefits of cloud-based systems. These aforementioned factors are expected to serve this segment with lucrative opportunities.
On-premise delivery mode involves the installation of services and solutions on computers present within the organization. Web-based LIMS solutions are delivered to users through web servers using the internet protocol. Web-based solutions comprise four elements including internet connection, web server, data administrator, and the software coding system. Utilizing the internet and web-based services provides an advantage of accessing the remotest of the areas using only one computer or monitoring device in labs. The increased adoption of cloud computing solutions is expected to slow down the growth of the web-based and on-premise segments over the forecast period.
The services segment dominated the market and accounted for a revenue share in 2022 and is is expected to witness lucrative growth over the forecast period. An increase in the outsourcing of LIMS solutions is contributing to the segment growth. As large pharmaceutical research labs lack the resources and skillset required for the deployment of analytics, these services are outsourced by them.
The CROs segment is expected to witness profitable growth during the forecast period. The CROs offer the laboratory informatics services in packages that include compliance with the promotional spend, social media analytics, manufacturing process, preventive maintenance, predictive analytics for medical devices failure, and benchmarking solutions. Growing awareness pertaining to the associated benefits of these solutions amongst users is expected to fuel their demand in the coming years.
The software segment is expected to witness lucrative growth over the forecast period due to the availability of technologically advanced software, such as SaaS, which offers effective information management solutions for laboratories. The software offered for laboratory informatics can perform critical functions such as data capture, storage, interpretation, and analysis. Periodic up-gradation of this software is necessary to be coordinated with the latest analytics methods.
The life science companies segment accounted for the largest revenue share of over 25.0% in 2022. This segment encompasses biobanks, molecular diagnostic and clinical research laboratories, contract service organizations, pharmaceutical and biotechnology companies, and academic research institutes. The demand for laboratory informatics is increasing in the life sciences industry to develop innovative products and improve product quality and operational efficiency. To fulfill these requirements, the need for more virtual and electronic laboratories is increasing. Laboratory informatics systems allow effective management of a large amount of data and break down research and discovery silos.
Increasing technological advancements in the healthcare sector owing to the rising R&D in the field of medicine are anticipated to fuel the demand for LIMS. Increasing adoption of LIMS in hospitals and research labs due to its growing application scope for patient engagement, workflow management, billing, patient health information tracking, and quality assurance is expected to augment the segment growth.
The CROs segment is expected to witness profitable growth during the forecast period due to the growing trend of outsourcing. Increasing adoption by outsourcing companies to curb healthcare costs is contributing to the lucrative growth of the CROs segment. LIMS also finds applications in forensic science, the metal and mining industry, and other pharma laboratories. The rising need to curb operational costs, coupled with the benefits associated with LIMS usage, is a key factor expected to contribute to the growth of this segment.
North America dominated the market and accounted for a revenue share of over 40.0% in 2022. The major factors contributing to the growth of this regional market are the policies supporting the deployment of laboratory information systems and the availability of infrastructure with high digital literacy. In addition, the burgeoning healthcare cost, coupled with the escalating pressure to bend the cost curve, resulted in the increased adoption of LIMS in this region. In addition, the presence of well-established pharma companies and the growing requirement to contain operational costs incurred in information management and analysis are the key factors contributing to the regional market growth.
In Asia Pacific, the market for laboratory informatics is expected to witness lucrative growth in the coming years owing to the increasing number of CROs offering LIMS solutions in this region. Major players outsource LIMS from the companies in this region to reduce the cost of LIMS support systems and improve operational efficiency. Developing economies such as India and China emerge as outsourcing hubs. In India, the prevalence of cardiovascular and infectious diseases has also led to the growth of eClinical services to a large extent. This is expected to lead to an increase in the demand for laboratory informatics over the forecast period. India has the potential to provide proper infrastructure for conducting clinical trials pertaining to affordable patient care and evidence-based management. The initiatives like these are expected to help penetrate lab informatics in China, thus boosting the market growth.
The market is highly fragmented with many small and large players operating in this space. This leads to intense competition within smaller players to sustain their position in the market. Moreover, the companies are providing customized LIMS solutions. Hence, rivalry within the industry is anticipated to be high during the forecast period. Besides, key players are contributing to the market growth by entering into partnerships and launching new products. In July 2021, GoMeyra has introduced GoMeyra MD, a next-generation health care management platform. Likewise, in August 2021, Abbott Informatics released STARLIMS Laboratory Execution System v1.1. This is built on the latest STARLIMS Quality Manufacturing QM 12.2. The introduction of such advanced products is projected to boost the market growth over the forecast period. Some prominent players in the global laboratory informatics market include:
Thermo Fisher Scientific, Inc.
Core Informatics
LabWare
PerkinElmer, Inc.
LabVantage Solutions, Inc.
LabLynx, Inc.
Agilent Technologies
ID Business Solutions Ltd.
McKesson Corporation
Waters Corporation
Abbott Informatics
Report Attribute |
Details |
Market size value in 2023 |
USD 3.5 billion |
Revenue forecast in 2030 |
USD 4.9 billion |
Growth Rate |
CAGR of 4.9% from 2023 to 2030 |
Base year for estimation |
2022 |
Historical data |
2017 - 2021 |
Forecast period |
2022 - 2030 |
Quantitative units |
Revenue in USD million/billion and CAGR from 2023 to 2030 |
Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
Segments covered |
Product, delivery mode, component, end-use, region |
Regional scope |
北美;欧洲;亚太地区;拉丁美洲; MEA |
Country scope |
U.S.; Canada; Germany; U.K.; France; Italy; Spain; Russia; China; Japan; India; Brazil; Mexico; South Africa; Saudi Arabia |
Key companies profiled |
Thermo Fisher Scientific, Inc.; Core Informatics; LabWare; PerkinElmer, Inc.; LabVantage Solutions, Inc.; LabLynx, Inc.; Agilent Technologies; ID Business Solutions Ltd.; McKesson Corporation; Waters Corporation; Abbott Laboratories |
Customization scope |
Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs.Explore purchase options |
这份报告预测全球收入增长, regional, and country levels, and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2017 to 2030. For the purpose of this study, Grand View Research has segmented the global laboratory informatics market report on the basis of product, delivery mode, component, end-use, and region:
Product Outlook (Revenue, USD Million, 2017 - 2030)
Laboratory Information Management Systems (LIMS)
Electronic Lab Notebooks (ELN)
Scientific Data Management Systems (SDMS)
Laboratory Execution Systems (LES)
Electronic Data Capture (EDC) & Clinical Data Management Systems (CDMS)
Chromatography Data Systems (CDS)
Enterprise Content Management (ECM)
Delivery Mode Outlook (Revenue, USD Million, 2017 - 2030)
On-premise
Web-hosted
Cloud-based
Component Outlook (Revenue, USD Million, 2017 - 2030)
Software
Services
End-use Outlook (Revenue, USD Million, 2017 - 2030)
Life Sciences
Pharmaceutical and Biotechnology Companies
Biobanks/Biorepositories
Contract Services Organizations
Molecular Diagnostics & Clinical Research Laboratories
Academic Research Institutes
CROs
Chemical Industry
F&B and Agriculture
Environmental Testing Labs
Petrochemical Refineries & Oil and Gas Industry
Other Industries
Regional Outlook (Revenue, USD Million, 2017 - 2030)
North America
U.S.
Canada
Europe
U.K.
Germany
France
Italy
Spain
Russia
Asia Pacific
Japan
China
India
拉丁美洲
Brazil
Mexico
Middle East & Africa
South Africa
Saudi Arabia
b.The global laboratory informatics market size was estimated at USD 3.3 billion in 2022 and is expected to reach USD 3.5 billion in 2023.
b.The global laboratory informatics market is expected to grow at a compound annual growth rate of 4.9% from 2023 to 2030 to reach USD 4.9 billion by 2030.
b.The Laboratory Information Management Systems (LIMS) segment dominated the global market for laboratory informatics and held the largest revenue share of over 45% in 2022.
b.The cloud-based delivery mode dominated the market for laboratory informatics and accounted for the largest revenue share of over 42% in 2021, and is expected to maintain its dominance throughout the forecast period.
b.The services segment dominated the market and accounted for a revenue share in 2022. The segment is anticipated to maintain its position over the forecast period.
"The quality of research they have done for us has been excellent."